Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control Trial

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 20, 2020

Primary Completion Date

April 16, 2024

Study Completion Date

June 16, 2024

Conditions
Chronic Liver Disease and Cirrhosis
Interventions
BEHAVIORAL

Home-Based Aerobic Exercise Program

Aerobic Exercise (AE) Group This intervention consists of a home-based aerobic exercise program emphasizing moderate-intensity walking, tailored to 40-60% of peak VO2 or Borg Scale 4-6 for those on beta blockers. Distinctive features include real-time session supervision via video conferencing and heart rate monitoring with a smart wristband. This approach ensures remote guidance, personalized intensity, and participant safety throughout the 8-week program.

BEHAVIORAL

Home-Based Aerobic and Resistance Exercise (ARE) Group

Participants engaged in a combined home-based aerobic and resistance exercise program. Aerobic sessions followed the same protocol as the AE group (3 days/week). Resistance training was performed 2 additional days per week using elastic resistance bands set at 40-50% of one-repetition maximum (1RM). Resistance exercises targeted major muscle groups, with each session consisting of 3 sets of 10 repetitions, and 1-3 minutes of rest between sets. All sessions were monitored and supervised remotely.

Trial Locations (1)

06100

Hacettepe University Faculty of Physical Therapy and Rehabilitation, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT06892366 - Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control Trial | Biotech Hunter | Biotech Hunter